Running an Oncology Program: Operations and the Job Behind the P&L
Staffing, volume ownership, and what the administrator's job actually contains.
Medsolve Dynamics works alongside oncology program leadership on capital, margin, and the operating decisions underneath the P&L.
Short field notes, recorded as they came up. Newest first.
Where Volume Responsibility Belongs in an Oncology Program, with Jeff Siupik
May 4, 2026 · Listen
Jeff Siupik, 35 years in oncology operations, on where volume responsibility actually belongs in a healthy program. The C-suite looks at P&L. The clinical team looks at compassionate care. Where leaders most often misallocate the volume expectation, and where it should sit instead. Full episode on YouTube.
Staff Is The Soul Of Your Program: Capital Discipline For Oncology Hiring And AI Tools
April 30, 2026 · Listen
Hiring and retention decisions are landing on the same desks as AI tool decisions, often in the same week. After 20 years on the vendor side, here is the discipline most programs are missing: the same questions you would ask of any capital line, applied to the people on the team and the tools being sold to replace them.
After 20 Years on the Vendor Side, What Medsolve Does for Cancer Programs
April 22, 2026 · Listen
After 20 years on the vendor side of oncology at GE HealthCare, ViewRay, and Varian, Yoel Bakas launched Medsolve Dynamics to work from your program side. In this episode, he walks through what Medsolve actually does: capital strategy on LINAC and theranostics purchases, service contract renegotiation before escalator clauses compound, financial case building for theranostics and benign disease service lines before capital is committed, and AI and software evaluation on clinical value and ROI rather than vendor claims. If you have a capital decision, a service contract renewal, a new service line, or an AI evaluation in front of you right now, this is who Medsolve was built for. LINAC capital strategy, oncology vendor negotiation, radiation oncology service contracts, theranostics service line, benign disease radiation therapy, AI in oncology, hospital operations.
Inside Oncology Operations: What Programs Are Dealing With Right Now, with Heather Turner
March 31, 2026 · Listen
Heather Turner has 14 years of experience in radiation oncology. Radiation therapist, operations manager for a new cancer center build, director. In this conversation she and Yoel Bakas talk about the real challenges programs are navigating in 2026. Staffing shortages across therapists, dosimetrists, physicists, and physicians. Workflow breakdowns between radiation oncology, medical oncology, and imaging. The administrative burden of prior authorization. AI tools being purchased before the problem is defined. Service contracts that have not been reviewed since signature. And the pressure of buying equipment when reimbursement just changed the math.
The role of Medsolve in providing a second set of eyes on projects.
March 17, 2026 · Listen
The conversation covers the importance of understanding and defining constraints, negotiating leverage, and the role of Medsolve in providing a second set of eyes on constraints.
-
Define your constraints.
-
Leverage comes from understanding and defining your constraints.
Medsolve Dynamics is just beginning.
March 17, 2026 · Listen
Yoel Bakas has spent 20 years in the medtech industry, focusing on structuring complex medtech deals and ensuring technology investments are mathematically successful. He shares a success story of unlocking $3 million in capital savings for a client and emphasizes the importance of preserving vendor relationships while ensuring hospital solvency. He expresses gratitude to his network and invites introductions for those navigating clinical ambition and financial pressure. The next chapter for Medsolve Dynamics is just beginning.
-
Medtech deal structuring.
-
Closing the gap between ROI and P&L.
-
Preserving vendor relationships.
More field notes: LINAC service contracts · Vendor negotiation · all seven topics